From February 6, 2024 to March 31, 2024, the company has repurchased 849,300 shares, representing 0.15% for CNY 14.12 million. With this, the company has completed the repurchase of 849,300 shares, representing 0.15% for CNY 14.12 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.62 CNY | +0.26% | +5.43% | -4.39% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.39% | 1.58B | |
+29.68% | 681B | |
+21.72% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.45% | 235B | |
+4.24% | 199B | |
-11.12% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- 600557 Stock
- News Jiangsu Kanion Pharmaceutical Co.,Ltd.
- Tranche Update on Jiangsu Kanion Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 7, 2024.